Early research (Phase 1)Study completedNCT00020124
What this trial is testing
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer
National Institutes of Health Clinical Center (CC)